AutoZone has received a consensus rating of Buy. The company’s average rating score is 2.50, and is based on 10 buy ratings, 7 hold ratings, and 1 sell rating.
Is AutoZone stock a good buy?
AutoZone currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period.
Is AutoZone stock overpriced?
In summary, AutoZone (NYSE:AZO, 30-year Financials) stock is believed to be modestly overvalued. The company’s financial condition is fair and its profitability is strong. Its growth ranks in the middle range of the companies in the industry of Retail – Cyclical.
Is AZO a buy?
Out of 17 analysts, 6 (35.29%) are recommending AZO as a Strong Buy, 5 (29.41%) are recommending AZO as a Buy, 5 (29.41%) are recommending AZO as a Hold, 1 (5.88%) are recommending AZO as a Sell, and 0 (0%) are recommending AZO as a Strong Sell.
Who owns the most stock in AutoZone?
Top 10 Owners of Autozone Inc
|The Vanguard Group, Inc.||9.05%||1,898,134|
|BlackRock Fund Advisors||5.20%||1,090,107|
|Fidelity Management & Research Co…||4.40%||922,275|
|SSgA Funds Management, Inc.||4.22%||884,423|
Why is AutoZone stock price so high?
Key Points. Revenue and earnings have both been growing since 2019 and earlier. The company’s commercial sector is seeing the biggest gains, which could be a benefit for stability. DIY orders are also up, especially with stimulus money in people’s pockets after the lockdowns.
How many times has AutoZone stock split?
When did AutoZone’s stock split? Our stock has split two for one on January 30, 1992 and April 20, 1994.
Who makes AZO?
AZO is distributed by i-Health Inc., of Cromwell, CT and all trademarks are used under license by i-Health, Inc. About i-Health: i-Health, Inc. is a consumer health and wellness company that develops, markets and distributes branded products that support wellness.